These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8697647)

  • 1. High levels of bcl-2 protein in the T lymphocytes of patients with Behçet's disease.
    Hamzaoui A; Hamzaoui K; Kooli C; Chabbou A; Hentati F; Ayed K
    Clin Exp Rheumatol; 1996; 14(1):106-7. PubMed ID: 8697647
    [No Abstract]   [Full Text] [Related]  

  • 2. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bcl-2 protein in active skin lesions of Behçet's disease.
    Senturk N; Yildiz L; Sullu Y; Kandemir B; Turanli AY
    Int J Dermatol; 2001 Dec; 40(12):747-50. PubMed ID: 11903667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
    Bariş YS; Yildiz L; Sentürk N; Kandemir B
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
    Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
    J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) according to activity of Behçet's disease.
    Lee JS; Park MJ; Park S; Lee ES
    J Dermatol Sci; 2012 Mar; 65(3):220-2. PubMed ID: 22336995
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease.
    Kose O; Stewart J; Waseem A; Lalli A; Fortune F
    Clin Exp Dermatol; 2008 Jan; 33(1):62-9. PubMed ID: 17983454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-x in T cells.
    Michaud GY; Kamesaki H; Cossman J
    Leuk Res; 1996 Aug; 20(8):683-91. PubMed ID: 8913322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistological studies in neuro-Behçet's disease.
    Hirohata S; Arai H; Matsumoto T
    Adv Exp Med Biol; 2003; 528():385-7. PubMed ID: 12918730
    [No Abstract]   [Full Text] [Related]  

  • 11. Behçet's disease. Report of twelve patients in the Mexican population.
    Lavalle Montalvo C; Alarcón-Segovia D; del Giudice-Knipping JA; Enríquez R
    Rev Invest Clin; 1981; 33(1):29-35. PubMed ID: 6973812
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells.
    Sastry KJ; Marin MC; Nehete PN; McConnell K; el-Naggar AK; McDonnell TJ
    Oncogene; 1996 Aug; 13(3):487-93. PubMed ID: 8760290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease.
    Triolo G; Accardo-Palumbo A; Dieli F; Ciccia F; Ferrante A; Giardina E; Sano CD; Licata G
    Arthritis Res Ther; 2003; 5(5):R262-8. PubMed ID: 12932289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophilic phlebitis is characteristic of intestinal Behçet's disease and simple ulcer syndrome.
    Hayasaki N; Ito M; Suzuki T; Ina K; Ando T; Kusugami K; Goto H
    Histopathology; 2004 Oct; 45(4):377-83. PubMed ID: 15469476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistological analysis of lymphocytes infiltrating the terminal ileum in a patient with intestinal Behçet's disease].
    Yamana S; Jones SL; Shimamoto T; Aoi K; Ishibe Y; Aoyama T; Takasugi K
    Ryumachi; 1986 Feb; 26(1):10-4. PubMed ID: 3487125
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.
    Valesini G; Pivetti-Pezzi P; Mastrandrea F; Moncada A; Cuomo M; Natali PG
    Clin Exp Immunol; 1985 Apr; 60(1):55-60. PubMed ID: 3874016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of vertebrobasilar artery system in neuro-Behçet and Behçet disease using magnetic resonance angiography.
    Kose E; Kamisli S; Dogan M; Tasolar S; Kahraman A; Oztanir MN; Sener S
    Anat Rec (Hoboken); 2014 Jul; 297(7):1302-5. PubMed ID: 24737739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behçet's disease.
    Düzgün N; Duman T; Keskin O; Morris Y; Tutkak H
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S100. PubMed ID: 20868585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.